NP+PA Perspectives in Dermatology | Page 3 of 0

Full Digital Editions:

NP+PA Perspectives in Dermatology: September-October 2025

NP+PA Perspectives in Dermatology: July-August 2025

NP+PA Perspectives in Dermatology: May-June 2025

NP+PA Perspectives in Dermatology: March-April 2025

NP+PA Perspectives in Dermatology: January-February 2025

Current Issue & Archives

Mycobacteroides abscessus: Identification and Treatment Challenges

J Clin Aesthet Dermatol. 2025;18(1–2 Suppl 1):S12–S14. by Blair Ferguson, APRN, DNP Mr. Ferguson is with Natura Dermatology and Cosmetics in Fort Lauderdale, Florida. Funding: No funding was provided for...

Beyond Skin Deep: The Systemic Impact of Topical Corticosteroids in Dermatology

J Clin Aesthet Dermatol. 2025;18(1–2 Suppl 1):S16–S20. by Douglas DiRuggiero, DMSc, MHS, PA-C, and Margaret DiRuggiero, BS, MS Dr. DiRuggiero is with the Skin Cancer and Cosmetic Dermatology Center in...

Selected Abstracts from Elevate-Derm West Conference

J Clin Aesthet Dermatol. 2025;18(1–2 Suppl 1):S36–S52. Acne Early acne improvements with fixed-dose clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel: What to expect in the first 4 weeks...

Maintenance Acne Treatment with Topical Tazarotene after Oral Isotretinoin: Overview and Case Reports

J Clin Aesthet Dermatol. 2024;17(11–12 Suppl 1):S14–S17. by Shanna M. Miranti, MPAS, PA-C Ms. Miranti is with Riverchase Dermatology and Cosmetic Surgery in Naples, Florida. FUNDING: No funding was received...

Selected Poster Abstracts from 16th Annual Dermatology Pearls Conference

J Clin Aesthet Dermatol. 2024;17(11-12 Suppl 1):S19–27. Acne Efficacy and safety of fixed-dose clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel in hispanic participants with moderate-to-severe...

Life and Career Coaching for NPs and PAs— Creating the Infrastructure for Effective Teledermatology Practice

J Clin Aesthet Dermatol. 2024;17(11–12 Suppl 1):S28 by Kasey D’Amato, PA-C, MPAP, and Kathryn Werner, PA-C Ms. D’Amato is President of Certified PA Consulting in Ft. Lauderdale, Florida. Ms. Werner is...

Don’t Let Beauty Blind You: Unveiling Clinical Diagnoses During Cosmetic Dermatology Practice

J Clin Aesthet Dermatol. 2024;17(11–12 Suppl 1):S30–S33. by Miguel A. Aristizabal, MD; Tara Soto, PA-C; Leila Tolaymat, MD; and Alison J. Bruce, MB ChB All authors are with the Department of Dermatology...

Dermatological Conditions in Skin of Color: An Update on Prurigo Nodularis in Skin of Color

by Archana M. Sangha, MMS, PA-C Ms. Sangha is a senior medical science liaison for Incyte Corporation in Wilmington, Delaware. Prior to that, she spent over a decade as a dermatology PA specializing in...

Previous 1 2 3 4 5 6 7 8 9 10 11 Next

Trending on JCAD TV

Chantel Hillestad, RN, MSN, DCNP, FNP-C: Restoring Pigmentation in Patients with Vitiligo

Watch Now

Ask Austin: Introduction to Publishing

Watch Now

Atopic Dermatitis Advisor Audio Series:

Incorporating Topical and Oral Treatments into Practice

Nicole Keeter, MSHS, PA-C, describes how to implement various JAK inhibitors into practice for the treatment of atopic dermatitis, psoriasis, and alopecia areata. She discusses how utilizing these JAK inhibitors in the treatment of atopic dermatitis has shown to provide a rapid decrease in symptoms, particularly pruritus.

JCAD

Journal of Clinical and Aesthetic Dermatology

JCAD Archives